By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments...
By Michael Erman and Leroy Leo (Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for...
Robust pipeline of over 90 drugs, vaccinations make up 38% of revenues Reported its highest quarterly sales in history in Q2 2022 Recession-resistant due to COVID-19 vaccine...
Despite the movement in the futures and currency markets. it’s a relatively light news day on the economic calendar. However, there’s a lot of inflation news this week...
The sell-off in PFE Stock After Earnings Is Based On Quick Trigger Fingers Pfizer (NYSE:PFE) stock is dropping in mid-day trading after the company delivered a mixed earnings...
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
| Average | 200.48 (+42.22% Upside) |
| High | 276.066 |
| Low | 143.8585 |
| Price | 140.96 |
| No. of Analysts | 15 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Strong Sell | Strong Sell | Neutral |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 128.64 | 129.55 | 127.78 | -1.17 | -0.90% | 1.38M | NYSE | |||
| 82.33 | 83.80 | 82.14 | -3.19 | -3.73% | 14.13M | NASDAQ | |||
| 83.68 | 86.28 | 83.22 | -2.41 | -2.80% | 52.81M | NASDAQ | |||
| 194.76 | 198.17 | 189.92 | +4.78 | +2.52% | 185.21M | NASDAQ | |||
| 61.08 | 62.17 | 60.11 | -2.95 | -4.61% | 12.36M | NYSE | |||
| 41.28 | 41.59 | 40.90 | -0.23 | -0.55% | 15.52M | NYSE | |||
| 3.16 | 3.36 | 2.79 | +0.15 | +4.98% | 76.36M | NYSE | |||
| 229.44 | 230.26 | 228.04 | -0.69 | -0.30% | 3.24M | NYSE | |||
| 28.72 | 29.32 | 28.47 | -0.35 | -1.20% | 7.48M | NASDAQ | |||
| 23.86 | 24.88 | 21.77 | +1.61 | +7.24% | 8.53M | NYSE | |||
| 163.36 | 164.85 | 163.10 | -1.25 | -0.76% | 7.01M | NYSE | |||
| 27.89 | 28.09 | 27.08 | +0.41 | +1.49% | 21.03M | NYSE | |||
| 136.18 | 136.32 | 134.95 | -0.76 | -0.56% | 4.83M | NYSE | |||
| 151.73 | 153.10 | 150.78 | -2.77 | -1.79% | 67.99M | NASDAQ | |||
| 11.96 | 12.13 | 11.60 | +0.34 | +2.93% | 26.10M | NASDAQ |